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Abstract
 
Aims
 
Intensive 5-day educational interventions for people with Type 1 diabetes have shown improved outcomes in a
number of European studies. The aim was to assess the effectiveness of a brief (2.5 days) psycho-educational intervention.
 
Methods
 
Our randomized trial in a secondary-care setting had 54 and 60 participants allocated to intervention and
control groups, respectively. Primary outcomes were HbA
 
1c
 
 and severe hypoglycaemia. Secondary outcomes were blood
pressure, weight, height, lipids and psychometric profile.
 
Results
 
HbA
 
1c
 
 showed no statistically significant change at 3 months [difference 
 
=
 
 0.01, 95% confidence interval (CI)
–0.23, 0.26, 
 
P
 
 
 
=
 
 0.92], 6 months (difference 
 
=
 
 –0.06, 95% CI –0.32, 0.20, 
 
P
 
 
 
=
 
 0.67) and 12 months (difference 
 
=
 
 0.01,
95% CI –0.30, 0.32, 
 
P
 
 
 
=
 
 0.94). Incidence of severe hypoglycaemia (per patient per year) in the intervention group (0.41)
and control group (0.48) was not statistically different. Treatment satisfaction improved at 3 months (difference 
 
=
 
 9.4, 95%
CI 5.2, 13.6, 
 
P
 
 
 
=
 
 0.0005), 6 months (difference 
 
=
 
 10.4, 95% CI 6.0, 14.8, 
 
P
 
 
 
=
 
 0.0005) and 12 months (difference 
 
=
 
 7.1,
95% CI 2.1, 12.1, 
 
P
 
 
 
=
 
 0.006). The ‘Managing psychological aspects’ and ‘Setting and achieving goals’ dimensions of the
Diabetes Empowerment Scale also showed significant improvement at 3, 6 and 12 months. Diabetes Knowledge Test,
Illness Perception Questionnaire, Hypoglycaemia Fear Scale and Short Form 36 showed no significant change.
 
Conclusions
 
This brief intervention had no significant impact on HbA
 
1c
 
 or severe hypoglycaemia, but improved
diabetes treatment satisfaction and patient empowerment. Current Controlled Trials ISRCTN75807800.
Diabet. Med. 25, 1447–1453 (2008)
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Introduction
 
Self-management is a critical component of preventive care in
people with diabetes [1,2]. Intensive educational interventions
providing self-management skills for people with diabetes
have reduced blood glucose concentration in a number of studies
[3–8]. This, in turn, reduces rates of complications [9,10].
In the UK, the Dose Adjustment for Normal Eating (DAFNE)
group was the first to deliver an effective educational programme
for Type 1 diabetes [8]. DAFNE is based on a successful in-
patient programme developed in Düsseldorf, Germany [3]
and is delivered in 35 h over five consecutive days. Many
diabetes teams in the UK have since developed relatively brief
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educational programmes delivered in 15–24  h over 4–
6 weeks. [11] The effectiveness of these interventions has not
been assessed in randomized controlled trials.
We report a pragmatic randomized controlled trial carried
out in a realistic clinical setting to determine the effectiveness
of a brief (2.5 days) psycho-educational intervention for self-
management in people with Type 1 diabetes.
 
Methods
 
Intervention
 
Philosophy and principles
 
BITES intervention is based on psychological theories of self-
regulation [12,13] and social learning [14,15]. The underlying
philosophy of the programme is that of patient empowerment
[16,17] and promoting self-management of diabetes. In the
delivery of BITES, we used basic principles of adult learning:
conceptualization (in the classroom), observation (classroom
and home), experimentation leading to expertise (home), and
reflection (classroom and at home after the intervention).
BITES also included use of cognitive behavioural techniques.
We sought to give participants insight into motivational principles
they could apply. Rationale was provided for using insulin that
is consistent with their illness cognitions (i.e. their view of their
diabetes) and enhancement of their self-efficacy (i.e. their feeling
of control over their diabetes). Changing negative to positive
thoughts and maintaining changes were discussed. BITES also
explored coping, control and strategies for prioritizing diabetes.
 
Design
 
A multiprofessional team comprising a consultant diabetologist,
diabetes specialist nurse, specialist diabetes dietician and clinical
health psychologist designed the BITES intervention.
 
Educational goals and learning outcomes
 
The BITES curriculum covers three educational themes:
understanding carbohydrates and diet, understanding insulin
adjustment and giving patients the skills and confidence to
self-manage diabetes. Learning outcomes covered under these
themes are listed in Table 1.
Pre- and post-meal blood glucose monitoring were promoted
with participants encouraged to self-adjust insulin doses according
to their carbohydrate intake, level of activity, anticipation of
exercise, climatic change on holiday, time zones and the type of
insulin regime. Participants were provided with a ready-reckoner
table to help estimate their initial carbohydrate:insulin ratios
based on their total daily insulin requirement. Further refinement
of carbohydrate:insulin ratios were made on an individual basis
based on pre- and post-meal testing. Participants were not given
fixed algorithms to titrate insulin doses. Carbohydrate estimation
was taught early in the course, with insulin titration skills
provided in a subsequent session, thus ensuring sufficient time
to practise carbohydrate skills, before introducing titration of
insulin. The timetable of the course listing its contents is provided
in Table 2.
Table 1 Educational goals and learning outcomes of the BITES 
intervention
1) Understanding carbohydrates and diet
  Analysing food content
  Dietary liberalization
  Understanding glycaemic index
  Practical carbohydrate counting
2) Understanding insulin adjustment
  Insulin and its effects
  Role of pre- and post-meal blood glucose testing
  Insulin:carbohydrate ratios 
  Impact of stress, exercise, and environment on blood glucose 
and insulin requirement
  Adjusting insulin for carbohydrates without using algorithm
3) Giving patients the confidence to self-manage diabetes
  Avoiding hypos
  Sick-day rules
  Complications
  Skills to effect and maintain change.
Table 2 Syllabus and timetable for brief educational intervention, BITES
Day 1 in week 1 (09.00–16.00 h) Day 2 in week 2 (09.00–16.00 h) Day 3 in week 6 (09.00–13.00 h)
1. Introduction 6. Feedback from last session & Workbook 11. Feedback from last session & Workbook
2. Freedom and control in day-to-day diabetes 7. Using insulin as a tool 12. Fine-tuning—activity, eating out & illness
3. Principles of healthy eating 8. Understanding insulin adjustment 13. ‘Going for Gold’ (motivational video)
4. Analysing food content & estimating 
carbohydrates
9. Blood glucose monitoring as a tool 
(including testing before & after meals)
14. Maintaining change
5. Group exercise—analysing food content 10. Exercise in ‘free diet’—combined food 
analysis and insulin adjustment
Workbook Workbook
Food analysis—practical exercises & 
daily comments
Food analysis & insulin adjustment—
daily comments
1 scheduled phone support call 1 scheduled phone support call 
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Delivery
 
A specifically trained diabetes specialist nurse and a specialist
diabetes dietician facilitated delivery in six groups of 8–10
participants as a 2.5-day course over a 6-week period using
pre-approved educational material. Gaps between sessions were
intended to help participants consolidate their understanding,
allowing time to practise, reflect and develop skills on an
individual basis.
 
Learning methods
 
Sessions were interactive and reflection in between sessions
encouraged. Group-based problem solving exercises were used
during the sessions. Participants completed a workbook in
between sessions and received feedback from peers and healthcare
professionals at the following session.
Participants were also introduced to a fictitious individual
with diabetes whom they mentored throughout the course and
discussed helping them with change. This allowed the participants
to offer advice on the need for change without excessive
personalization, and provided continuity as new concepts and
learning were reviewed.
 
Assurance of treatment fidelity
 
Treatment fidelity was ensured by the use of a written curriculum,
pre-approved educational materials, observation by an inde-
pendent researcher and using the same set of health professionals
to deliver the intervention.
 
Participants and protocol
 
Participants were recruited from people with diabetes attending
our specialist diabetes service in a hospital setting. Eligibility
criteria were: Type 1 diabetes for 
 
>
 
 12 months, multiple
injection therapy for 
 
≥
 
 2 months, minimum age of 18 years and
ability to read and write. York Research Ethics Committee
(Ref: 01/08/016) approved the study protocol.
Postal invitations were sent to eligible participants along
with information about the study. Willing respondents were
seen at randomization clinics, where the research team verified
eligibility and obtained written informed consent. An independent
evaluator then allocated participants using block randomiza-
tion (block size 
 
=
 
 6) to intervention or control groups using
sealed envelopes in strict ascendant order. The intervention
group was offered the course in six groups of 8–10. Participants
in both groups attended the four assessments at baseline, 3, 6
and 12 months, plus their usual care. After the course, usual
care continued.
The control group were seen in their usual diabetes clinic, in
addition to their study appointments. Patients had access to
Diabetes Specialist Nurses and Specialist Diabetes Dietician,
and access to the Clinical Health Psychologist by referral. The
control group received the full course 12 months later.
The full protocol for the study is available as an open source
publication [18].
 
Primary outcomes
 
Haemoglobin A
 
1c
 
 (HbA
 
1c
 
) was measured (Diabetes Complications
Control Trial aligned) and severe hypoglycaemia recorded at
baseline, 3, 6 and 12 months. Severe hypoglycaemia was
defined as a recorded episode in which the patient required
assistance with treatment and either documented blood glucose
 
<
 
 2.7 mmol/l or detected clinical signs that required oral carbo-
hydrate administered by a third party, subcutaneous glucagon
or intravenous glucose.
 
Secondary outcomes
 
Blood pressure, weight, height, body mass index (BMI), lipid
profile and the number of daily insulin injections were used as
secondary end-points. Participants were asked to complete a
psychosocial and knowledge questionnaire (221 items) with
Cronbach 
 
α
 
 0.60–0.94. The questionnaire included the following
scales: Medical Outcomes Study 36-Item Short-form Health
Survey (SF-36) to measure general health status [19]; Illness
Perception Questionnaire (IPQ) to measure participants’
perceptions of their diabetes [20]; Diabetes Knowledge Test
(DKT) to assess participants’ knowledge about diabetes [21];
Diabetes Empowerment Scale (DES) to measure participants’
self-efficacy in caring for their diabetes [17]; Diabetes Treatment
Satisfaction Questionnaire (DTS-Q) to measure participants’
satisfaction with their current treatment for diabetes [22];
Hypoglycaemia Fear Scale (HFS) to measure participants’ worries
about hypoglycaemia and their associated behaviours [23]; and
Diabetes Health Profile (DHP) with its three subscales: psychological
distress, barriers to activity, and disinhibited eating [24].
 
Statistical analysis
 
We used intention to treat analysis of covariance (
 
ANCOVA
 
)
adjusting for baseline scores. To have 80% power to detect a
1.0% difference in HbA
 
1c
 
, which we deemed to be of clinical
significance, required us to recruit at least 90 participants. A
 
P
 
-value of 
 
<
 
 0.05 was considered to be statistically significant.
 
Technical data
 
HbA
 
1c
 
 was analysed by an ion-exchange high-performance
liquid chromatography method [25] (Tosoh Medics, Foster City,
CA, USA). The normal range for healthy subjects (mean 
 
±
 
 2 
 
SD
 
)
is 4.4–6.1%. Blood pressure, weight and height (and calculated
BMI in kg/m
 
2
 
) were measured by standardized methods.
 
Results
 
Patients meeting eligibility criteria (
 
n
 
 
 
=
 
 232) were invited by
post to participate. Of the 117 patients attending randomiza-
tion, 54 were allocated to the intervention group and 60 to the
control group. Figure 1 shows the flow of participants in the study.
Analysis was by intention to treat. Characteristics of partici-
pants in the two groups were comparable at entry (Table 3).
No adverse events were reported.
 
Primary outcomes
 
Although HbA
 
1c
 
 fell at 3 months in both groups from 8.7 to
8.4%, there were no statistically significant differences 
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between the groups at 3 months [difference 
 
=
 
 0.01, 95%
confidence interval (CI) of difference –0.23, 0.26, 
 
P
 
 
 
=
 
 0.92],
6 months (difference 
 
=
 
 –0.06, 95% CI –0.32, 0.20, 
 
P
 
 
 
=
 
 0.67)
or 12  months (difference 
 
=
 
  0.01, 95% CI –0.30, 0.32,
 
P
 
 
 
=
 
 0.94). There were 0.41 episodes of severe hypoglycaemia
(per patient per year) in the intervention group and 0.48
episodes in the control group with no statistical difference at
12 months. Seven participants in the intervention group and
six in the control group had a baseline HbA
 
1c
 
 
 
<
 
 7.5%. An
analysis was performed excluding these participants and no
statistically significant differences were observed. A summary
of biophysical outcomes is provided in Table 4.
 
Secondary outcomes
 
Lipids, blood pressure, use of insulin and BMI demonstrated
no statistical significance between the two groups (Table 3). In
both groups, 94% of participants were injecting insulin four or
five times per day at baseline and 98% at 12 months.
DKT, IPQ, HFS and SF-36 scores did not show any statistically
significant improvement. In DH, no statistically significant
findings were seen between the two groups except in the
‘barriers to activity’ dimension, which improved at 3 months
(difference 
 
=
 
 –4.5, 95% CI –7.4, –1.5, 
 
P
 
 
 
=
 
 0.003), 6 months
(difference 
 
=
 
  –4.6, 95% CI –8.4, –0.9, 
 
P
 
 
 
=
 
 0.02)  and
12 months (difference 
 
=
 
 –3.5, 95% CI –6.4, –0.7, 
 
P
 
 
 
=
 
 0.02).
The ‘Managing psychological aspects’ dimension of DES
showed improvement in the intervention group at 3 months
(difference 
 
=
 
  3.7, 95% CI 1.2, 6.1, 
 
P
 
 
 
=
 
 0.004),  6 months
(difference 
 
=
 
 3.9, 95% CI 1.3, 6.4, 
 
P
 
 
 
=
 
 0.003) and 12 months
(difference 
 
=
 
 4.6, 95% CI 2.1, 7.2, 
 
P
 
 
 
=
 
 0.0005). The ‘Setting
and achieving goals’ dimension of DES also showed a positive
change at 3 months (difference 
 
=
 
 3.1, 95% CI 0.6, 5.6, 
 
P
 
 
 
= 0.02),
6 months (difference = 3.8, 95% CI 0.9, 6.7, P = 0.01) and
12 months (difference = 3.7, 95% CI 0.6, 6.9, P = 0.02).
Treatment satisfaction on DTS-Q improved at 3 months
(difference = 9.4, 95% CI 5.2, 13.6, P = 0.0005), 6 months
(difference =  10.4, 95% CI 6.0, 14.8, P = 0.0005)  and
12 months (difference = 7.1, 95% CI 2.1, 12.1, P = 0.006).
Psychological outcomes are summarized in Table 5.
Discussion
In this educational intervention, we promoted principles of
self-titration of insulin based on liberal diet and physical
activity. No significant weight gain or deterioration in blood
FIGURE 1 Participant recruitment and flow in the BITES study.
Table 3 Comparability of intervention, control and refusal groups at 
baseline
Variable
Intervention
group 
(n = 54)
Control 
group 
(n = 60)
Refusals 
(N = 74)
Male (%)  50  40  50
Age (years)  41 ± 10  41 ± 12  41 ± 14
Duration of diabetes (years) 19.7 ± 12.7 19.4 ± 11.0 19.0 ± 11
HbA1c (%) 8.7 ± 1.51 8.7 ± 1.13 8.8 ± 1.6
BMI (kg/m2) 26.3 ± 3.74  27 ± 4.17 26.6 ± 4.0
Total cholesterol (mmol/l) 5.0 ± 1.05 5.2 ± 0.83 NA
Triglycerides (mmol/l) 1.7 ± 1.30 1.9 ± 1.43 NA
HDL-cholesterol (mmol/l) 1.8 ± 0.50 1.8 ± 0.83 NA
LDL-cholesterol (mmol/l) 2.4 ± 0.85 2.6 ± 0.80 NA
Values are expressed as means (SD).
BMI, body mass index; HDL, high-density lipoprotein; 
LDL, low-density lipoprotein; NA, not available.Original article DIABETICMedicine
© 2008 The Authors.
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pressure, lipid profile, insulin doses or BMI was observed with
this approach. Our study adds to the body of evidence demon-
strating that promotion of dietary liberalization does not lead
to a decline in HbA1c [3,6–8] or increase in serious hypoglycaemic
episodes [26,27].
Glycaemic control
HbA1c improved significantly from baseline in both inter-
vention and control groups at 3, 6 and 12 months. However,
there were no statistically significant differences between the
two groups, failing to replicate improvements in other studies
[3,6–8]. There are a number of possible explanations for this.
First, all participants were already on multiple daily
injections and many participants had received carbohydrate
estimation and insulin titration training as part of their routine
care. Although knowledge is a precondition for self-efficacy
and not an indicator of it, the lack of improvement in knowledge
score suggests self-efficacy skills may already have been common
in this group of patients.
Table 4 Difference between means of bio-physical outcomes obtained between intervention and control groups at 3, 6 and 12 months
Outcomes
3 months 6 months 12 months
Difference between 
means (95% CI) P
Difference between 
means (95% CI) P
Difference between 
means (95% CI) P
HbA1c (%) 0.01 (–0.23, 0.26) 0.92 –0.06 (–0.32, 0.20) 0.67 0.01 (–0.30, 0.32) 0.94
Cholesterol (mmol/l) N/A N/A –0.12 (–0.34, 0.10) 0.28 –0.04 (–0.18, 0.26) 0.70
Triglycerides (mmol/l) N/A N/A –0.28 (–0.64, 0.08) 0.13 –0.13 (–0.42, 0.16) 0.37
Severe hypoglycaemia* N/A N/A N/A N/A –0.05 (–0.61, 0.50) 0.85
Body mass index (kg/m2) –0.01 (–0.35, 0.33) 0.96 –0.07 (–0.48, 0.34) 0.74 0.07 (–0.56, 0.42) 0.77
Total daily insulin dose (units) 0.33 (–2.17, 2.84) 0.79 2.33 (–0.46, 5.11) 0.10 0.29 (–3.30, 3.88) 0.87
Fifty-four patients in intervention group and 60 patients in the control group. *Severe episodes per annum.
Table 5 Psychosocial outcomes at 3, 6 and 12 months* 
Outcomes Dimensions
3 months 6 months 12 months
Difference 
between means
(95% CI) P
Difference 
between means
(95% CI) P
Difference 
between means
(95% CI) P
Short Form 36 Physical health (PCS) 1.4 (–1.6, 4.3) 0.35 2.2 (–0.7, 5.0) 0.14 1.9 (–0.8, 4.6) 0.17
Mental health (MCS) 1.1 (–2.6, 4.8) 0.57 0.78 (–2.6, 4.2) 0.65 0.33 (–3.3, 4) 0.86
Diabetes 
Empowerment 
Scale
Managing psychological aspects 3.7 (1.2, 6.1) 0.004 3.9 (1.3, 6.4) 0.003 4.6 (2.1, 7.2) 0.0005
Setting and achieving goals 3.1 (0.6, 5.6) 0.02 3.8 (0.9, 6.7) 0.01 3.7 (0.6, 6.9) 0.02
Dissatisfaction and readiness 
to change
2.1 (–1.0, 5.1) 0.19 0.20 (–2.7, 3.1) 0.89 2.87 (–0.3, 6.1) 0.08
Hypoglycaemia 
Fear Scale
Behaviour –0.29 (–3.4, 2.8) 0.85 −.01 (–2.9, 2.9) 0.99 –1.2 (–4.2, 1.9) 0.45
Worry –3.0 (–7.0, 1.1) 0.15 –2.4 (–7.2, 2.4) 0.33 –1.4 (–6.2, 3.4) 0.57
Diabetes Treatment
Satisfaction
Treatment satisfaction 9.4 (5.2, 13.6) 0.0005 10.4 (6.0, 14.8) 0.0005 7.1 (2.1, 12.1) 0.006
Hyperglycaemia –4.1 (–12.0, 3.8) 0.31 –3.2 (–10.8, 4.4) 0.40 2.0 (–5.3, 9.4) 0.59
Hypoglycaemia 0.9 (–7.0, 8.9) 0.82 –0.2 (–7.7, 7.3) 0.95 3.5 (–3.7, 10.8) 0.34
Illness (Diabetes) 
Perception 
Questionnaire
Timeline 0.5 (–2.97, 3.98) 0.77 2.6 (–0.72, 5.9) 0.12 –3.2 (–7.2, 0.8) 0.11
Consequences 1.5 (–1.75, 4.81) 0.36 –3.6 (–8.0, 0.8) 0.11 –4.1 (–8.7, 0.5) 0.08
Cure/control 1.9 (–1.02, 4.80) 0.20 3.0 (–0.12, 6.1) 0.06 3.7 (–0.3, 7.8) 0.07
Causes –0.58 (–3.6, 2.48) 0.71 2.6 (–1.3, 6.6) 0.18 0.64 (–2.7, 4) 0.70
Diabetes Health 
Profile
Psychological distress –2.0 (–4.8, 0.70) 0.14 –1.7 (–4.6, 1.1) 0.24 –2.3 (–5.0, 0.4) 0.93
Barriers to activity –4.5 (–7.4, –1.5) 0.003 –4.6 (–8.4, –0.9) 0.02 –3.5 (–6.4, –0.7) 0.02
Disinhibited eating –2.0 (–7.0, 3.10) 0.45 –3.1 (–7.3, 1.2) 0.16 –3.6 (–8.3, 1) 0.12
Diabetes 
Knowledge Test
Knowledge 2.2 (–0.07, 4.5) 0.06 1.8 (–0.7, 4.2) 0.15 0.55 (–3.2, 4.3) 0.77
Intervention group n = 54, and control n = 60.
*Statistical analysis was performed using ANCOVA, adjusting for imbalances at baseline between groups.
PCS, Physical Components of Health; MCS, Mental Components of Health.DIABETICMedicine Brief psycho-educational intervention in Type 1 diabetes • J. T. George et al.
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Second, the mean baseline HbA1c was lower in this study
than in the DAFNE and Düsseldorf studies. This suggests a
reduced potential for lowering HbA1c in this study, where no
lower limit was set to ensure that the results were more widely
applicable to standard diabetes care in the UK. However, lack
of improvement in HbA1c persisted even after excluding
participants in intervention and control groups with a baseline
HbA1c < 7.5%.
Third, the delivery of our intervention in 2.5 days spread
over 6 weeks may have diluted any positive impact on glycaemic
control. The direct continuous support of other group
members in a sustained intensive environment could well be
the key to longer term behavioural change and glycaemic
improvement achieved by other studies. It is also important to
note that our intervention did not promote the use of a fixed
algorithm to titrate insulin. Participants self-adjusted insulin
doses according to their carbohydrate intake, level of activity,
anticipation of exercise, climatic change on holiday, time
zones and their insulin regime.
Psychological outcomes
The BITES intervention led to some improvements in a
number of psychological outcomes. Key areas of improvement
were treatment satisfaction (DTS-Q) and self-empowerment
(DES). Managing psychological aspects, setting and achieving
goals and barriers to activity showed statistically significant
improvements, suggesting success as a psychological inter-
vention. The significant improvement in ‘barriers to activity’
score in the DHP scale is clinically relevant. This sub-scale
addresses perceived barriers and operant anxiety resulting
from diabetes, and the intervention positively influenced this.
Although not statistically significant, ‘disinhibited eating’ and
‘psychological distress’ subscales of the DHP also improved.
Treatment satisfaction improved even in the absence of
statistically significant glycaemic improvement. This could be
due to poor correlation between these two variables, as
suggested by previous studies [28]. However, it is important to
note that HbA1c did improve significantly in both arms of our
study when compared with baseline, possibly influencing the
perception of treatment satisfaction.
We used a large inventory of psychological instruments in
assessing the psychological impact of the intervention. Discordant
results noted in different scales (e.g. Treatment satisfaction vs.
Fear of hypoglycaemia) in our study emphasize the need to
design interventions with clear psychological objectives along
with clinical objectives.
Strengths and weaknesses
Our study has both strengths and weaknesses. We studied the
impact of the educational intervention in a ‘real-world’ setting and
did not specify cut-off thresholds for HbA1c. Although some
details of the BITES curriculum are different from other brief
interventions in the UK, the educational objectives [11] are similar.
We made every effort to ensure that the control group
received less input than the intervention group. However,
principles of self-management from the BITES course may
have spilled over into the day-to-day practice of healthcare
providers. No statistically significant intergroup differences
were noted in frequency of use of general practitioner, hospital
out-patients, specialist nurse or emergency service resources,
nor was there any difference in acute or non-acute sick
days.
Cluster randomization with multiple care delivery teams
may overcome this, but ethical and practical considerations
prevent such a study design in the UK. Moreover, open invitation
may have led to recruitment of participants with high levels of
motivation who may already have adopted many of the behaviours
and principles that the course sought to instil. However,
selection of patients based on their pre-intervention level of
motivation would have reduced the clinical applicability of
our study findings.
Implications for clinical practice and research
There are up to 20 different interventions developed and used
in different parts of the UK [11], with recommendations to
offer such interventions to all patients with diabetes [2,29,30].
To improve patient access and optimize resource allocation,
many of these interventions are delivered in 15–24 h over 4–6
weeks, compared with 35 h in five consecutive days as in the
DAFNE and Düsseldorf studies. The lack of biophysical
effectiveness seen in our study may warrant a closer examination
of other brief interventions, although the content and delivery
of these educational interventions are likely to differ.
Although delivered in a group setting, BITES provided
considerable opportunity for individualized learning. Participants
had to complete a workbook between sessions, and feedback
was provided for workbook entries at the beginning of the
subsequent session. As resource pressures often mandate
provision of diabetes education in a group setting, further
studies comparing the efficacy of one-to-one, group-based or
hybrid learning methods have to be welcomed.
The interplay between biophysical markers of diabetes,
psychological outcomes and perceptions of treatment satisfaction
is complex [17,21–24], hence the use of a wide range of scales
in our study to quantify psycho-educational outcomes.
Although the inventories are often perceived to be practically
challenging, all participants in our studies completed them and
the feedback has been positive. We would therefore recom-
mend inclusion of multiple relevant psychometric instruments
in future studies in the domain of diabetes education.
Conclusions
Our brief psycho-educational intervention promoting dietary
liberalization in Type 1 diabetes showed no significant impact
on HbA1c or severe hypoglycaemia, but led to gains in treatment
satisfaction and empowerment.Original article DIABETICMedicine
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